Lipocine appointed Michael J. Grissinger to its board, effective Aug. 3, 2026.
Grissinger spent more than two decades at Johnson & Johnson, including VP roles leading worldwide pharmaceutical licensing and corporate development, M&A.
He previously worked 12 years at Ciba-Geigy in finance, marketing, business development.
LPCN•
